本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

4.60
-0.0700-1.50%
盤後4.50-0.1000-2.17%19:44 EDT
成交量:46.85萬
成交額:217.12萬
市值:3.14億
市盈率:-2.09
高:4.80
開:4.70
低:4.51
收:4.67
資料載入中...
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/03/22

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/10

重要事件披露

8-K - Current report
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/16

重要事件披露

8-K - Current report
2022/11/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/23

重要事件披露

8-K - Current report